|
NCT02345265
|
2015-03-01 |
Olaparib and Cediranib Maleate in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer
|
Phase 2
|
Not Yet Recruiting
|
|
NCT02325518
|
2014-12-01 |
Comparison of IOP (Intraocular Pressure)-Lowering Efficacy and Safety of AZORGA® Ophthalmic Suspension and COSOPT® Ophthalmic Solution
|
Phase 4
|
Recruiting
|
|
NCT02250612
|
2014-10-01 |
SYL040012, Treatment for Open Angle Glaucoma
|
Phase 2
|
Recruiting
|
|
NCT02246764
|
2014-09-01 |
Double-masked Study of AR-13324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension (Rocket-3)
|
Phase 3
|
Recruiting
|
|
NCT02202616
|
2014-07-01 |
Prospective Cohort Study for the Real - Life Effectiveness Evaluation of GlycOpyrronium With IndacatERol Combination in the Management of COPD in Canada (POWER Study)
|
Phase 4
|
Recruiting
|
|
NCT02207491
|
2014-07-01 |
Double-masked Study of AR-13324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
|
Phase 3
|
Active, Not Recruiting
|
|
NCT02207621
|
2014-07-01 |
A Double-masked Study of AR-13324 in Patients With Glaucoma and Ocular Hypertension
|
Phase 3
|
Recruiting
|
|
NCT02145884
|
2014-05-01 |
Topical Timolol Gel for the Treatment of Infantile Hemangiomas
|
Phase 1/Phase 2
|
Not Yet Recruiting
|
|
NCT02014142
|
2013-12-01 |
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
|
Phase 2
|
Recruiting
|
|
NCT02072031
|
2013-12-01 |
Phase II Study of Anlotinib Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma（RCC）
|
Phase 2
|
Active, Not Recruiting
|
|
NCT01978600
|
2013-10-01 |
Evaluation of Intraocular Pressure Using Simbrinza™ in Patients With Open-Angle Glaucoma or Ocular Hypertension.
|
Phase 4
|
Completed
|
|
NCT01984931
|
2013-10-01 |
Study of Trimebutine Maleate (NEWBUTIN SR 300 mg Tab)for Treatment of Post Operative Nausea and Vomiting
|
Phase 3
|
Recruiting
|
|
NCT01933919
|
2013-08-01 |
A Phase 3 Study of SME3110 in Pediatric/Adolescent Subjects With Obsessive Compulsive Disorder
|
Phase 3
|
Recruiting
|
|
NCT01448057
|
2013-07-01 |
Evaluation of Efficacy and Safety of Tablets of Paracetamol, Dimethindene Maleate and Phenylephrine Hydrochloride in Reducing Symptoms of Common Cold and Flu
|
Phase 3
|
Recruiting
|
|
NCT01533220
|
2013-06-01 |
Efficacy of Nasal Naphazoline Hydrocloride + Pheniramine Maleate + Panthenol Compared With Naphazoline Hydrocloride in the Symptomatic Control of Nasal Congestion and Nasopharyngeal
|
Phase 3
|
Active, Not Recruiting
|
|
NCT01822639
|
2013-04-01 |
A Fixed Dose Combination Amlodipine + Enalapril Bioavailability Study
|
Phase 1
|
Completed
|
|
NCT01845038
|
2013-04-01 |
Multi-Arm Feasibility Study Evaluating OTX-TP Compared to Timolol in Treatment of Subjects With Open Angle Glaucoma
|
Phase 1
|
Completed
|
|
NCT01806376
|
2013-03-01 |
A Phase I Study of Subutinib Maleate Capsules on Toleration and Pharmacokinetics
|
Phase 1
|
Recruiting
|
|
NCT01985334
|
2012-12-01 |
Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD Regimen
|
Phase 4
|
Recruiting
|
|
NCT01707381
|
2012-11-01 |
BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension
|
Phase 2
|
Completed
|
|
NCT01699464
|
2012-10-01 |
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
|
Phase 2
|
Completed
|
|
NCT01759394
|
2012-10-01 |
A Open-label, Three-period, Partial-replicate Design Study to Evaluate the Inter- and Intrasubject Variability of the Avatrombopag To-be-marketed Formulation Administered as Single Doses of 40 mg to Healthy Subjects Receiving a Low-fat Meal
|
Phase 1
|
Completed
|
|
NCT01685398
|
2012-09-01 |
Topical Timolol for Superficial Infantile Hemangioma
|
Phase 3
|
Recruiting
|
|
NCT01607671
|
2012-06-01 |
Treatment Study for Ischemic Optic Neuropathy With Opthalmic Timolol Maleate 0.5%
|
Phase 1
|
Not Yet Recruiting
|
|
NCT01514721
|
2012-06-01 |
Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination) From Prior Therapy
|
Phase 4
|
Terminated
|
|
NCT01512225
|
2012-05-01 |
Enhancing Breast Milk Production With Domperidone in Mothers of Preterm Neonates
|
Phase 2
|
Recruiting
|
|
NCT01433978
|
2012-04-01 |
A Phase 3, Multicenter, Randomized, Double-blind, Active-controlled, Parallel-group Trial With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Oral E5501 Versus Eltrombopag, in Adults With Chronic Immune Thrombocytopenia (Idiopathic Thrombocytopenic Purpura)
|
Phase 3
|
Terminated
|
|
NCT01438840
|
2012-03-01 |
Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Amendment 02)
|
Phase 3
|
Completed
|
|
NCT01514734
|
2012-03-01 |
Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on COMBIGAN® (Brimonidine 0.2%/Timolol 0.5% Fixed Combination) Therapy in Brazil
|
Phase 4
|
Terminated
|
|
NCT01254604
|
2011-12-01 |
Preservative-Free Tafluprost (MK-2452) for the Treatment of Open-Angle Glaucoma or Ocular Hypertension (MK-2452-002)
|
Phase 3
|
Completed
|
|
NCT01518244
|
2011-12-01 |
Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin America
|
Phase 4
|
Completed
|
|
NCT01355289
|
2011-11-01 |
Chronic Hepatitis C Virus Related Thrombocytopenia to Evaluate the Effects of E5501
|
Phase 2
|
Completed
|
|
NCT01484197
|
2011-11-01 |
A Study to Evaluate the Effects of Indacaterol Maleate as a New Formulation in the Concept 1 Device
|
Phase 2
|
Completed
|
|
NCT01978015
|
2011-10-01 |
Blood-aqueous Barrier Changes After the Use of Timolol and Prostaglandin Analogues Fixed Combination in Pseudophakic Patients With POAG
|
Phase 4
|
Completed
|
|
NCT01177852
|
2011-10-01 |
Evaluation of Efficacy and Safety in Control Cough and the Relief of Nasal Symptoms in Children 2-12 Years Old,Suffering From Cough and Acute Rhinitis
|
Phase 3
|
Not Yet Recruiting
|
|
NCT01415401
|
2011-09-01 |
Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada
|
Phase 4
|
Completed
|
|
NCT01390961
|
2011-08-01 |
Comparison of Tolerability Between Two Allergy Drops
|
Phase 4
|
Enrolling By Invitation
|
|
NCT01437748
|
2011-08-01 |
Closing Volume Interpretation and Bronchodilators Effect
|
Phase 4
|
Completed
|
|
NCT01364051
|
2011-05-01 |
Cediranib Maleate and Selumetinib in Treating Patients With Solid Malignancies
|
Phase 1
|
Active, Not Recruiting
|
|
NCT01310855
|
2011-05-01 |
Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma
|
Phase 2
|
Terminated
|
|
NCT01377051
|
2011-05-01 |
Effect of Indacaterol Maleate in Chronic Obstructive Pulmonary Disease (COPD) on Lung Volume and Related Dyspnea
|
Phase 4
|
Completed
|
|
NCT01336569
|
2011-02-01 |
Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol
|
Phase 4
|
Completed
|
|
NCT01302249
|
2011-02-01 |
AR-12286 in Combination With Latanoprost
|
Phase 2
|
Completed
|
|
NCT01279083
|
2011-01-01 |
Safety and Efficacy Trial to Treat Open-Angle Glaucoma or Ocular Hypertension
|
Phase 1/Phase 2
|
Completed
|
|
NCT01301391
|
2011-01-01 |
Study Of Oral PHA-848125AC In Patients With Malignant Thymoma Previously Treated With Multiple Lines Of Chemotherapy
|
Phase 2
|
Recruiting
|
|
NCT01191008
|
2010-10-01 |
Long Term Use Of Xalacom In Patients Glaucoma Or Ocular Hypertension
|
Phase 4
|
Active, Not Recruiting
|
|
NCT01260688
|
2010-10-01 |
Cediranib Maleate With or Without Dasatinib in Patients With Hormone-Resistant Prostate Cancer Resistant to Treatment With Docetaxel
|
Phase 2
|
Active, Not Recruiting
|
|
NCT01229111
|
2010-10-01 |
Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers
|
Phase 2
|
Active, Not Recruiting
|
|
NCT01471158
|
2010-09-01 |
Patient Preference Comparison of AZARGA Versus COSOPT in Patients With Glaucoma
|
Phase 4
|
Completed
|
|
NCT01026961
|
2010-09-01 |
Safety of Phenylephrine Hydrochloride, Acetaminophen, Dimethindene Maleate Compared to Phenylephrine Hydrochloride Alone in Healthy Volunteers
|
Phase 1/Phase 2
|
Withdrawn
|
|
NCT01208051
|
2010-09-01 |
Cediranib Maleate With or Without Lenalidomide in Treating Patients With Thyroid Cancer
|
Phase 1/Phase 2
|
Active, Not Recruiting
|
|
NCT01427868
|
2010-09-01 |
Bioequivalence of LB80380 Free Base and Maleate Salt Tablets
|
Phase 1
|
Completed
|
|
NCT01229930
|
2010-06-01 |
Carboplatin and Paclitaxel With or Without Cediranib Maleate in Treating Patients With Metastatic or Recurrent Cervical Cancer That Cannot Be Removed by Surgery
|
Phase 2
|
Completed
|
|
NCT01132820
|
2010-06-01 |
Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer
|
Phase 2
|
Active, Not Recruiting
|
|
NCT01131234
|
2010-05-01 |
Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors
|
Phase 1
|
Completed
|
|
NCT00979862
|
2010-03-01 |
Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma
|
Phase 1
|
Active, Not Recruiting
|
|
NCT01064648
|
2010-03-01 |
Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
|
Phase 1/Phase 2
|
Recruiting
|
|
NCT01116648
|
2010-03-01 |
Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer
|
Phase 1/Phase 2
|
Recruiting
|
|
NCT01062425
|
2010-02-01 |
Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
|
Phase 2
|
Active, Not Recruiting
|
|
NCT01170884
|
2009-12-01 |
Comparing Safety and Efficacy of Combigan® and Lumigan® With Lumigan® Alone in Glaucoma or Ocular Hypertension Subjects Treated With Xalatan®
|
Phase 4
|
Completed
|
|
NCT01131546
|
2009-12-01 |
Efficacy and Safety of Levamlodipine Besylate Compared to Amlodipine Maleate in Patients With Essential Hypertension
|
Phase 4
|
Completed
|
|
NCT01332071
|
2009-11-01 |
Avandamet Bioequivalence Study Brazil - Fed Administration
|
Phase 1
|
Completed
|
|
NCT01011439
|
2009-11-01 |
Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma
|
Phase 2
|
Recruiting
|
|
NCT00937482
|
2009-08-01 |
Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer
|
Phase 1
|
Terminated
|
|
NCT00966576
|
2009-07-01 |
Efficacy and Safety of Adding Azarga to Prostaglandin Monotherapy
|
Phase 4
|
Completed
|
|
NCT00928590
|
2009-07-01 |
Safety Study of DuoTrav APS in Patients With Open-Angle Glaucoma or Ocular Hypertension
|
Phase 3
|
Completed
|
|
NCT00927901
|
2009-06-01 |
Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Salts in Patients With Asthma
|
Phase 2
|
Completed
|
|
NCT00427973
|
2009-05-01 |
AZD2171 in Treating Patients With Locally Advanced Unresectable or Metastatic Liver Cancer
|
Phase 2
|
Terminated
|
|
NCT00879099
|
2009-04-01 |
Interaction Study of Timolol Eye Drops and Paroxetine Capsules
|
Phase 1
|
Completed
|
|
NCT00800423
|
2009-01-01 |
Effect of Topical Brimonidine on Post Cataract Surgery Corneal Edema
|
Phase 3
|
Not Yet Recruiting
|
|
NCT00811850
|
2008-12-01 |
Comparing Effects of Two Fixed Combinations Ophthalmic Solutions on Ocular Blood Flow
|
Phase 4
|
Completed
|
|
NCT00811564
|
2008-12-01 |
An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension Subjects
|
Phase 4
|
Completed
|
|
NCT00804648
|
2008-11-01 |
Patient Satisfaction With Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension
|
Phase 4
|
Completed
|
|
NCT00795340
|
2008-11-01 |
Cediranib, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
|
Phase 3
|
Completed
|
|
NCT01926288
|
2008-10-01 |
Efficacy and Safety of Entecavir Maleate Tablets in Chinese Patients With Hepatitis B
|
Phase 4
|
Active, Not Recruiting
|
|
NCT00753168
|
2008-09-01 |
Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma
|
Phase 1/Phase 2
|
Completed
|
|
NCT00759239
|
2008-09-01 |
Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
|
Phase 4
|
Completed
|
|
NCT01831011
|
2008-07-01 |
Mildronate for Acute Ischemic Stroke
|
Phase 2
|
Completed
|
|
NCT00735449
|
2008-07-01 |
Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension Subjects
|
Phase 4
|
Completed
|
|
NCT00891475
|
2008-05-01 |
Palliative Radiofrequency Ablation in Metastatic Renal Cell Carcinoma Patients
|
Phase 1/Phase 2
|
Completed
|
|
NCT00475150
|
2008-05-01 |
Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
|
Phase 2
|
Completed
|
|
NCT01871740
|
2008-05-01 |
CSPPT- Chronic Kidney Diseases Study
|
Phase 4
|
Active, Not Recruiting
|
|
NCT00794885
|
2008-05-01 |
China Stroke Primary Prevention Trial
|
Phase 4
|
Completed
|
|
NCT00662506
|
2008-04-01 |
Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
|
Phase 1/Phase 2
|
Active, Not Recruiting
|
|
NCT00588900
|
2008-03-01 |
Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab
|
Phase 2
|
Active, Not Recruiting
|
|
NCT00624702
|
2008-02-01 |
Tolerability of Indacaterol Salts (Maleate, Xinafoate and Acetate) in Comparison to Placebo in Patients With Mild to Moderate Persistent Asthma
|
Phase 1
|
Completed
|
|
NCT00605306
|
2008-01-01 |
Safety and Tolerability of Indacaterol Maleate/Mometasone Furoate Delivered Via the Twisthaler® Device After 14 Days Treatment in Patients With Mild to Moderate Asthma
|
Phase 2
|
Completed
|
|
NCT00527124
|
2007-11-01 |
Docetaxel and Prednisone With or Without Cediranib in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
|
Phase 2
|
Active, Not Recruiting
|
|
NCT00619346
|
2007-11-01 |
Randomized, Double-Blind Phase 1 Safety and Tolerability Study of Pafuramidine Maleate (DB289) in Healthy Subjects
|
Phase 1
|
Terminated
|
|
NCT00557440
|
2007-11-01 |
Investigation of the 24 Hour Forced Expiratory Flow in 1 Second (FEV1) Profile of a Single Dose of Indacaterol/Mometasone Delivered Via the TWISTHALER® Device in Adult Patients With Persistent Asthma
|
Phase 2
|
Completed
|
|
NCT00519753
|
2007-08-01 |
Success of Transitioning Uncontrolled Glaucoma Patients From Prior Mono or Adjunctive Therapy to DuoTrav
|
Phase 4
|
Completed
|
|
NCT00551564
|
2007-07-01 |
Study to Determine the Utility of Novel Technologies and Biomarkers to Measure Human Response to Rosiglitazone Maleate
|
Phase 1
|
Completed
|
|
NCT00326599
|
2007-06-01 |
Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
|
Phase 2
|
Completed
|
|
NCT00568178
|
2007-06-01 |
An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2))
|
Phase 3
|
Completed
|
|
NCT00458731
|
2007-05-01 |
Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma
|
Phase 1
|
Completed
|
|
NCT00484419
|
2007-05-01 |
Effects of Colesevelam HCl, Rosiglitazone, Sitagliptin on Control of Blood Glucose and Lipids in Type 2 Diabetes Patients Whose Blood Glucose Isn't Completely Controlled With Metformin
|
Phase 3
|
Completed
|
|
NCT00545064
|
2007-05-01 |
Dry Eye Study With Cosopt® Over 8 Weeks in Patients With Open-Angle Glaucoma or Ocular Hypertension (0507A-152)(COMPLETED)
|
Phase 4
|
Completed
|
|
NCT00612066
|
2007-04-01 |
Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease)
|
Phase 2
|
Terminated
|
|
NCT00449956
|
2007-03-01 |
MK0507A Clinical Study in Patients With Glaucoma and Ocular Hypertension (0507A-149)(COMPLETED)
|
Phase 3
|
Completed
|
|
NCT00465803
|
2007-03-01 |
A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension
|
Phase 3
|
Completed
|
|
NCT00458978
|
2007-02-01 |
Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer
|
Phase 2
|
Active, Not Recruiting
|
|
NCT00403637
|
2006-11-01 |
Efficacy and Safety of Single Doses of Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) Compared to Placebo in Patients With Persistent Asthma
|
Phase 2/Phase 3
|
Completed
|
|
NCT00616642
|
2006-10-01 |
Rosiglitazone in Treating Patients With Pituitary Tumors
|
Phase 2
|
Terminated
|
|
NCT00396604
|
2006-10-01 |
Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) in Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2/Phase 3
|
Completed
|
|
NCT00410904
|
2006-10-01 |
AZD2171 and Pemetrexed Disodium in Treating Patients With Relapsed Non-Small Cell Lung Cancer
|
Phase 2
|
Completed
|
|
NCT00353028
|
2006-10-01 |
Fluvoxamine Maleate in the Treatment of Depression/Depressive State : A Post-marketing Clinical Study in Children and Adolescents
|
Phase 4
|
Completed
|
|
NCT00362726
|
2006-09-01 |
Drug Interaction Study With Atazanavir Administered With and Without Ritonavir and a Cytochrome P450 Substrate Rosiglitazone
|
Phase 1
|
Completed
|
|
NCT00352768
|
2006-08-01 |
Fluvoxamine Maleate in the Treatment of Obsessive-Compulsive Disorder: A Post-marketing Clinical Study in Children and Adolescents
|
Phase 4
|
Terminated
|
|
NCT00369174
|
2006-06-01 |
Rosiglitazone Maleate in Treating Patients With Oral Leukoplakia
|
Phase 2
|
Completed
|
|
NCT00546286
|
2006-05-01 |
A Study to Evaluate the Effectiveness of Cosopt® as First Line Therapy (MK-0507A-153)
|
Phase 3
|
Completed
|
|
NCT00302341
|
2006-05-01 |
DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP)
|
Phase 3
|
Terminated
|
|
NCT00321724
|
2006-05-01 |
AZD2171 in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
|
Phase 2
|
Completed
|
|
NCT00326872
|
2006-05-01 |
AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
|
Phase 2
|
Active, Not Recruiting
|
|
NCT00330577
|
2006-04-01 |
24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients
|
Phase 4
|
Completed
|
|
NCT00278343
|
2006-04-01 |
Cediranib Maleate in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer
|
Phase 2
|
Active, Not Recruiting
|
|
NCT00303862
|
2006-03-01 |
AZD2171 in Treating Patients With Refractory Metastatic Kidney Cancer
|
Phase 2
|
Terminated
|
|
NCT00326664
|
2006-03-01 |
AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors
|
Phase 1
|
Active, Not Recruiting
|
|
NCT00245063
|
2006-03-01 |
AZD2171 in Treating Patients With Recurrent Small Cell Lung Cancer
|
Phase 2
|
Completed
|
|
NCT00243061
|
2006-01-01 |
AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma
|
Phase 2
|
Completed
|
|
NCT00273455
|
2006-01-01 |
Lumigan Versus Cosopt
|
Phase 4
|
Completed
|
|
NCT00305656
|
2006-01-01 |
AZD2171 in Treating Patients With Recurrent Glioblastoma Multiforme
|
Phase 2
|
Completed
|
|
NCT00238394
|
2005-12-01 |
Cediranib Maleate in Treating Patients With Locally Advanced or Metastatic Liver Cancer
|
Phase 2
|
Completed
|
|
NCT00227760
|
2005-12-01 |
Cediranib Maleate in Treating Patients With Recurrent or Metastatic Kidney Cancer That Cannot Be Removed By Surgery
|
Phase 2
|
Completed
|
|
NCT00309946
|
2005-12-01 |
Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery
|
Phase 2
|
Completed
|
|
NCT00273442
|
2005-11-01 |
Assessing Cosopt Switch Patients
|
Phase 4
|
Completed
|
|
NCT00243074
|
2005-11-01 |
S0509: AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery
|
Phase 2
|
Completed
|
|
NCT00287521
|
2005-11-01 |
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
|
Phase 2
|
Completed
|
|
NCT00275028
|
2005-10-01 |
AZD2171 in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer
|
Phase 2
|
Completed
|
|
NCT00273481
|
2005-09-01 |
Cosopt Versus Xalacom
|
Phase 4
|
Completed
|
|
NCT00243230
|
2005-09-01 |
Vicriviroc (SCH 417690) in Combination Treatment With Optimized ART Regimen in Experienced Subjects (VICTOR-E1) (Study P03672AM6)
|
Phase 2
|
Completed
|
|
NCT00244881
|
2005-09-01 |
A Phase II Study of AZD2171 in Breast Cancer Stage IV (10006202)
|
Phase 2
|
Completed
|
|
NCT00245154
|
2005-09-01 |
Paclitaxel and Carboplatin With or Without Cediranib Maleate in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
|
Phase 2/Phase 3
|
Completed
|
|
NCT00343408
|
2005-08-01 |
AZD2171 and Standard Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer or Colorectal Cancer
|
Phase 1
|
Completed
|
|
NCT00108017
|
2005-07-01 |
Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED)
|
Phase 3
|
Completed
|
|
NCT00686829
|
2005-06-01 |
Vicriviroc (SCH 417690) Treatment Protocol in HIV-Infected Subjects: A Rollover Study for ACTG Protocol A5211 (Study P04100AM4)(COMPLETED)
|
Phase 2
|
Completed
|
|
NCT00822055
|
2005-05-01 |
Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension
|
Phase 4
|
Completed
|
|
NCT00273429
|
2005-04-01 |
Cosopt Versus Xalatan
|
Phase 4
|
Completed
|
|
NCT00107250
|
2005-01-01 |
AZD2171 and Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)
|
Phase 1
|
Completed
|
|
NCT00822081
|
2005-01-01 |
Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension
|
Phase 4
|
Completed
|
|
NCT00116831
|
2005-01-01 |
Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes
|
Phase 3
|
Completed
|
|
NCT00822497
|
2004-10-01 |
Efficacy of Music Therapy Protocols for Burn Debridement
|
Phase 1
|
Completed
|
|
NCT00098852
|
2004-10-01 |
Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid Cancer
|
Phase 2
|
Active, Not Recruiting
|
|
NCT00293787
|
2004-06-01 |
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
|
Phase 3
|
Completed
|
|
NCT00853294
|
2003-09-01 |
Fasting Study of Chlorpheniramine Polistirex and Hydrocodone Polistirex Capsules and Tussionex® Pennkinetic® Extended Release Oral Suspension
|
Phase 1
|
Completed
|
|
NCT00853190
|
2003-09-01 |
Fed Study of Chlorpheniramine Polistirex and Hydrocodone Polistirex Capsules and Tussionex® Pennkinetic® Extended Release Oral Suspension
|
Phase 1
|
Completed
|
|
NCT00311389
|
2003-01-01 |
A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension
|
Phase 3
|
Completed
|
|
NCT00061542
|
2003-01-01 |
Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-Forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular Hypertension.
|
Phase 3
|
Completed
|
|
NCT00407212
|
2002-01-01 |
A Study of Three Doses of TCH346 in Patients With Early Parkinson's Disease to Evaluate Safety and Efficacy
|
Phase 1/Phase 2
|
Completed
|
|
NCT00003070
|
2000-09-01 |
Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer
|
Phase 3
|
Completed
|
|
NCT00004180
|
1999-10-01 |
Rosiglitazone in Treating Patients With Liposarcoma
|
Phase 2
|
Active, Not Recruiting
|
|
NCT00006398
|
1993-08-01 |
Prevention of Esophageal Varices by Beta-Adrenergic Blockers
|
Phase 3
|
Completed
|